Charles Schwab’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19B | Buy |
|
|||||
|
2025
Q1 | $1.22B | Sell |
|
|||||
|
2024
Q4 | $4.12B | Buy |
|
|||||
|
2024
Q3 | $3.77B | Buy |
|
|||||
|
2024
Q2 | $3.28B | Sell |
|
|||||
|
2024
Q1 | $3.37B | Buy |
|
|||||
|
2023
Q4 | $2.99B | Buy |
|
|||||
|
2023
Q3 | $3.16B | Buy |
|
|||||
|
2023
Q2 | $3.15B | Buy |
|
|||||
|
2023
Q1 | $3.41B | Buy |
|
|||||
|
2022
Q4 | $3.74B | Buy |
|
|||||
|
2022
Q3 | $3.07B | Buy |
|
|||||
|
2022
Q2 | $3.36B | Buy |
|
|||||
|
2022
Q1 | $3.1B | Buy |
|
|||||
|
2021
Q4 | $3.12B | Sell |
|
|||||
|
2021
Q3 | $2.3B | Sell |
|
|||||
|
2021
Q2 | $2.14B | Buy |
|
|||||
|
2021
Q1 | $1.83B | Buy |
|
|||||
|
2020
Q4 | $1.55B | Sell |
|
|||||
|
2020
Q3 | $1.47B | Buy |
|
|||||
|
2020
Q2 | $1.3B | Sell |
|
|||||
|
2020
Q1 | $1.3B | Sell |
|
|||||
|
2019
Q4 | $1.57B | Buy |
|
|||||
|
2019
Q3 | $1.4B | Buy |
|
|||||
|
2019
Q2 | $1.56B | Buy |
|
|||||
|
2019
Q1 | $1.49B | Buy |
|
|||||
|
2018
Q4 | $1.51B | Sell |
|
|||||
|
2018
Q3 | $1.55B | Buy |
|
|||||
|
2018
Q2 | $1.27B | Buy |
|
|||||
|
2018
Q1 | $1.23B | Buy |
|
|||||
|
2017
Q4 | $1.25B | Buy |
|
|||||
|
2017
Q3 | $1.21B | Buy |
|
|||||
|
2017
Q2 | $1.12B | Buy |
|
|||||
|
2017
Q1 | $1.07B | Buy |
|
|||||
|
2016
Q4 | $1B | Buy |
|
|||||
|
2016
Q3 | $981M | Buy |
|
|||||
|
2016
Q2 | $957M | Sell |
|
|||||
|
2016
Q1 | $815M | Buy |
|
|||||
|
2015
Q4 | $868M | Buy |
|
|||||
|
2015
Q3 | $806M | Sell |
|
|||||
|
2015
Q2 | $881M | Sell |
|
|||||
|
2015
Q1 | $948M | Buy |
|
|||||
|
2014
Q4 | $842M | Buy |
|
|||||
|
2014
Q3 | $752M | Buy |
|
|||||
|
2014
Q2 | $710M | Buy |
|
|||||
|
2014
Q1 | $727M | Buy |
|
|||||
|
2013
Q4 | $617M | Sell |
|
|||||
|
2013
Q3 | $641M | Buy |
|
|||||
|
2013
Q2 | $605M | Buy |
|